Literature DB >> 33067838

A rabbit model for evaluating ocular damage from acrolein toxicity in vivo.

Suneel Gupta1,2, Michael K Fink1,2, Lynn M Martin1,2, Prashant R Sinha1,2, Jason T Rodier1,3, Nishant R Sinha1,2, Nathan P Hesemann1,3, Shyam S Chaurasia1,2, Rajiv R Mohan1,2,3.   

Abstract

Acrolein is a highly reactive and volatile unsaturated aldehyde commonly used for producing scores of commercial products. It has been recognized as a chemical weapon since its use during World War I, and more recently, in Syria. Acrolein exposure causes severe eye, skin, and lung damage in addition to many casualties. In the eye, it causes severe pain, eyelid swelling, corneal burns, and vision impairment. Very little information is available about how acrolein damages the cornea and causes vision loss. At present, the lack of clinically relevant animal models limits evaluation of acrolein toxicity and mechanisms specific to the eye. We aim to standardize the mode of delivery and exposure duration of acrolein, damaging the rabbit eye in vivo as an ocular injury model for studying the toxicity of acrolein and developing medical countermeasures. Rabbit eyes were exposed to two modes of delivery (topical and vapor) for different durations (1-5 minutes). Clinical ophthalmic examinations with a slit lamp, stereomicroscope, fluorescein dye, pachymeter, tonometer, and tearing examinations in live rabbits were performed at various times up to 4 weeks. Corneas were histologically diagnosed for transparency, fibrosis, collagens, and neovascularization. Our study successfully established an in vivo rabbit model for evaluating acrolein toxicity to the eye, accounting for different modes and durations of exposure. Published 2020. This article is a U.S. government work and is in the public domain in the USA.

Entities:  

Keywords:  acrolein; cornea; corneal dysfunction; ocular inflammation; rabbit model

Mesh:

Substances:

Year:  2020        PMID: 33067838      PMCID: PMC9206444          DOI: 10.1111/nyas.14514

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   6.499


  42 in total

Review 1.  The keratocyte: corneal stromal cell with variable repair phenotypes.

Authors:  Judith A West-Mays; Dhruva J Dwivedi
Journal:  Int J Biochem Cell Biol       Date:  2006-04-03       Impact factor: 5.085

Review 2.  The molecular basis of corneal transparency.

Authors:  John R Hassell; David E Birk
Journal:  Exp Eye Res       Date:  2010-07-03       Impact factor: 3.467

Review 3.  Horizons in therapy for corneal angiogenesis.

Authors:  Surekha Maddula; Don K Davis; Soumya Maddula; Michael K Burrow; Balamurali K Ambati
Journal:  Ophthalmology       Date:  2011-03       Impact factor: 12.079

4.  Regulation of leukotriene B4 secretion by human corneal, conjunctival, and meibomian gland epithelial cells.

Authors:  Afsun Sahin; Wendy R Kam; Raheleh Rahimi Darabad; Kimberly Topilow; David A Sullivan
Journal:  Arch Ophthalmol       Date:  2012-08

5.  Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair.

Authors:  Zhaohui Feng; Wenwei Hu; Yu Hu; Moon-shong Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

6.  Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.

Authors:  Rajiv R Mohan; Ashish Tandon; Ajay Sharma; John W Cowden; Jonathan C K Tovey
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

Review 7.  The molecular effects of acrolein.

Authors:  J P Kehrer; S S Biswal
Journal:  Toxicol Sci       Date:  2000-09       Impact factor: 4.849

8.  Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.

Authors:  Rajiv R Mohan; Gregory S Schultz; Jong Wook Hong; Rahul R Mohan; Steven E Wilson
Journal:  Exp Eye Res       Date:  2003-03       Impact factor: 3.467

Review 9.  Cellular and extracellular matrix modulation of corneal stromal opacity.

Authors:  Andre A M Torricelli; Steven E Wilson
Journal:  Exp Eye Res       Date:  2014-10-01       Impact factor: 3.467

10.  Decorin antagonizes corneal fibroblast migration via caveolae-mediated endocytosis of epidermal growth factor receptor.

Authors:  Rajiv R Mohan; Ratnakar Tripathi; Ajay Sharma; Prashant R Sinha; Elizabeth A Giuliano; Nathan P Hesemann; Shyam S Chaurasia
Journal:  Exp Eye Res       Date:  2019-01-03       Impact factor: 3.770

View more
  4 in total

1.  Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.

Authors:  Suneel Gupta; Michael K Fink; Duraisamy Kempuraj; Nishant R Sinha; Lynn M Martin; Landon M Keele; Prashant R Sinha; Elizabeth A Giuliano; Nathan P Hesemann; Sudhanshu P Raikwar; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Mol Ther       Date:  2022-07-02       Impact factor: 12.910

2.  Glutathione is a potential therapeutic target for acrolein toxicity in the cornea.

Authors:  Suneel Gupta; Sabeeh Kamil; Prashant R Sinha; Jason T Rodier; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Toxicol Lett       Date:  2021-01-06       Impact factor: 4.271

Review 3.  The Adverse Effects of Air Pollution on the Eye: A Review.

Authors:  Chia-Ching Lin; Chien-Chih Chiu; Po-Yen Lee; Kuo-Jen Chen; Chen-Xi He; Sheng-Kai Hsu; Kai-Chun Cheng
Journal:  Int J Environ Res Public Health       Date:  2022-01-21       Impact factor: 3.390

Review 4.  Autophagy in Extracellular Matrix and Wound Healing Modulation in the Cornea.

Authors:  Duraisamy Kempuraj; Rajiv R Mohan
Journal:  Biomedicines       Date:  2022-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.